Literature DB >> 16191492

Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings.

Ann J Brown1, David A Tendler, Robert G McMurray, Tracy L Setji.   

Abstract

OBJECTIVE: To report a case of biopsy-documented nonalcoholic steatohepatitis (NASH), which improved appreciably through moderate exercise and weight loss in a young woman with polycystic ovary syndrome (PCOS) and insulin resistance.
METHODS: We present a detailed case report, including laboratory and pathologic findings. In addition, we review the recent literature regarding the association of insulin resistance with NASH and PCOS.
RESULTS: A 24-year-old woman was referred to the Duke Gastroenterology Clinic for evaluation of long-term high serum aminotransferase levels. She also reported a history of chronically irregular menses, infertility, and hirsutism and was diagnosed with PCOS. Subsequent glucose tolerance testing suggested the presence of insulin resistance. Liver biopsy findings were consistent with severe nonalcoholic steatohepatitis. Under the supervision of her physician and an exercise physiologist, the patient initiated a diet and exercise program that resulted in an 11.5% weight loss during approximately 8 months and yielded normalization of her aminotransferase levels. A repeat liver biopsy done 13 months after the initial biopsy revealed a substantial decrease in steatosis and a reduction in inflammation.
CONCLUSION: Women with PCOS and insulin resistance have an increased risk of developing many of the consequences of the dysmetabolic syndrome, including type 2 diabetes, hypertension, and hyperlipidemia. This case report suggests that fatty liver and NASH may be other important diseases to identify in such women. It also demonstrates the improvement in this condition with moderate exercise and weight loss.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16191492     DOI: 10.4158/EP.11.5.319

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  18 in total

Review 1.  Nonalcoholic fatty liver disease and polycystic ovary syndrome.

Authors:  Evangeline Vassilatou
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Authors:  Stavroula A Paschou; Stergios A Polyzos; Panagiotis Anagnostis; Dimitrios G Goulis; Christina Kanaka-Gantenbein; Irene Lambrinoudaki; Neoklis A Georgopoulos; Andromachi Vryonidou
Journal:  Endocrine       Date:  2019-09-19       Impact factor: 3.633

Review 3.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

Review 4.  Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Authors:  Carly E Kelley; Ann J Brown; Anna Mae Diehl; Tracy L Setji
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 5.  A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.

Authors:  P Riley; J O'Donohue; M Crook
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

Review 6.  Endocrine and liver interaction: the role of endocrine pathways in NASH.

Authors:  Paola Loria; Lucia Carulli; Marco Bertolotti; Amedeo Lonardo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

7.  Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol.

Authors:  Shahin Merat; Mohsen Aduli; Rozana Kazemi; Masoud Sotoudeh; Nahid Sedighi; Masoud Sohrabi; Reza Malekzadeh
Journal:  Dig Dis Sci       Date:  2007-11-30       Impact factor: 3.199

8.  NAFLD, Estrogens, and Physical Exercise: The Animal Model.

Authors:  Jean-Marc Lavoie; Abdolnaser Pighon
Journal:  J Nutr Metab       Date:  2011-08-10

9.  Prevalence of hepatic steatosis in women with polycystic ovary syndrome.

Authors:  Ritu Karoli; Jalees Fatima; Ashok Chandra; Uma Gupta; Faraz-Ul Islam; Gagandeep Singh
Journal:  J Hum Reprod Sci       Date:  2013-01

10.  Metformin in nonalcoholic steatohepatitis: a randomized controlled trial.

Authors:  Rozana Kazemi; Mohsen Aduli; Masoud Sotoudeh; Reza Malekzadeh; Nahid Seddighi; Sadaf Ghajarieh Sepanlou; Shahin Merat
Journal:  Middle East J Dig Dis       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.